Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 3.93% is 27% below its 5-year average of 5.41%, near the low end of its 5-year range (3.93%–6.26%).
As of the fiscal period ended Wednesday, December 31, 2025. 19.63% below its 12-month average of 4.89%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
3.93%
RETURN ON ASSETS (ROA) AVG TTM
4.89%
RETURN ON ASSETS (ROA) AVG 3Y
5.25%
RETURN ON ASSETS (ROA) AVG 5Y
5.41%
RETURN ON ASSETS (ROA) AVG 10Y
5.18%
RETURN ON ASSETS (ROA) AVG 15Y
5.03%
RETURN ON ASSETS (ROA) AVG 20Y
5.14%
CURRENT VS TTM AVG
-19.63%
CURRENT VS 3Y AVG
-25.21%
CURRENT VS 5Y AVG
-27.36%
CURRENT VS 10Y AVG
-24.06%
CURRENT VS 15Y AVG
-21.80%
CURRENT VS 20Y AVG
-23.51%
SECTOR MEDIAN · HEALTHCARE
4.97%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-20.93%
vs the sector median at left
Elevance Health Inc.
Market Cap
$81.51B
Return on Assets (ROA)
3.93%
TTM Avg
4.89%
3Y Avg
5.25%
5Y Avg
5.41%
Market Cap
$78.57B
Return on Assets (ROA)
10.37%
TTM Avg
11.40%
3Y Avg
12.40%
5Y Avg
16.97%
Market Cap
$87.16B
Return on Assets (ROA)
11.30%
TTM Avg
10.43%
3Y Avg
10.23%
5Y Avg
10.42%
Market Cap
$73.82B
Return on Assets (ROA)
4.08%
TTM Avg
2.99%
3Y Avg
3.50%
5Y Avg
3.82%
Market Cap
$69.46B
Return on Assets (ROA)
8.27%
TTM Avg
5.66%
3Y Avg
4.50%
5Y Avg
3.49%
Market Cap
$100.24B
Return on Assets (ROA)
5.78%
TTM Avg
5.08%
3Y Avg
5.08%
5Y Avg
2.52%
Market Cap
$60.57B
Return on Assets (ROA)
3.12%
TTM Avg
2.14%
3Y Avg
2.52%
5Y Avg
0.85%
Market Cap
$60.00B
Return on Assets (ROA)
2.24%
TTM Avg
3.00%
3Y Avg
3.04%
5Y Avg
2.95%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Elevance Health Inc. (ELV) | $81.51B | 3.93% | 4.89% | 5.25% | 5.41% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $78.57B | 10.37% | 11.40% | 12.40% | 16.97% |
| HCA Healthcare, Inc. (HCA)vs › | $87.16B | 11.30% | 10.43% | 10.23% | 10.42% |
| Cigna Corporation (CI)vs › | $73.82B | 4.08% | 2.99% | 3.50% | 3.82% |
| Boston Scientific Corporation (BSX)vs › | $69.46B | 8.27% | 5.66% | 4.50% | 3.49% |
| McKesson Corporation (MCK)vs › | $100.24B | 5.78% | 5.08% | 5.08% | 2.52% |
| Cencora, Inc. (COR)vs › | $60.57B | 3.12% | 2.14% | 2.52% | 0.85% |
| Becton, Dickinson and Company (BDX)vs › | $60.00B | 2.24% | 3.00% | 3.04% | 2.95% |
| GSK plc (GSK)vs › | $103.56B | 7.15% | 6.85% | 11.28% | 9.07% |
| Cardinal Health, Inc. (CAH)vs › | $53.87B | 2.75% | 2.42% | 0.86% | -0.71% |
ROA
3.9%
ROE
11.1%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 4.66% |
| 2024-12-31 | 5.12% |
| 2023-12-31 | 5.50% |
| 2022-12-31 | 5.74% |
| 2021-12-31 | 6.26% |
| 2020-12-31 | 5.18% |
| 2019-12-31 | 6.14% |
| 2018-12-31 | 5.17% |
| 2017-12-31 | 5.38% |
| 2016-12-31 | 3.72% |
| 2015-12-31 | 4.06% |
| 2014-12-31 | 4.08% |
| 2013-12-31 | 4.39% |
| 2012-12-31 | 4.41% |
| 2011-12-31 | 4.97% |
| 2010-12-31 | 5.63% |
| 2009-12-31 | 9.10% |
| 2008-12-31 | 5.15% |
| 2007-12-31 | 6.43% |
| 2006-12-31 | 5.98% |
| 2005-12-31 | 4.79% |
| 2004-12-31 | 2.36% |
| 2003-12-31 | 5.77% |
| 2002-12-31 | 4.41% |
| 2001-12-31 | 5.40% |
| 2000-12-31 | 3.96% |
| 1999-12-31 | 0.93% |
| 1998-12-31 | 3.95% |
